Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chekkera Shammi

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Psychiatry|March 16, 2005
Single versus multiple daily dosing of lithium: renal effectsChekkera Shammi
Psychiatric Services (Washington, D.C.)|August 10, 2005
Overstating the case about recovery?Gary Remington, Chekkera Shammi
CNS Spectrums|July 27, 2004
The use of pharmacotherapy in the prodrome of schizophreniaGary Remington, Chekkera Shammi
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 19, 2007
Clozapine-induced hypersalivation: a review of treatment strategiesSanjeev Sockalingam, Chekkera Shammi, Gary Remington
The Journal of Clinical Psychiatry|September 18, 2009
Treatment of clozapine-induced hypersalivation with ipratropium bromide: a randomized, double-blind, placebo-controlled crossover studySanjeev Sockalingam, Chekkera Shammi, Gary Remington
British Journal of Hospital Medicine (London, England : 2005)|November 3, 2007
Managing the neuropsychiatric complications of hepatitis C treatmentSanjeev Sockalingam, Chekkera Shammi, Vicky Stergiopoulos
CNS Drugs|September 28, 2005
Augmentation strategies in clozapine-resistant schizophreniaGary Remington, Amitabha Saha, Siow-Ann Chong, et al.
CNS Drugs|February 16, 2006
Augmenting strategies in clozapine-resistant schizophreniaGary Remington, Amitabha Saha, Siow-Ann Chong, et al.
Schizophrenia Research|July 8, 2010
Determining rates of hepatitis C in a clozapine treated cohortSanjeev Sockalingam, Chekkera Shammi, Valerie Powell, et al.
Journal of Clinical Psychopharmacology|November 12, 2005
"Extended" antipsychotic dosing: rationale and pilot dataGary Remington, Philip Seeman, Chekkera Shammi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Psychiatry|March 16, 2005
Single versus multiple daily dosing of lithium: renal effectsChekkera Shammi
Psychiatric Services (Washington, D.C.)|August 10, 2005
Overstating the case about recovery?Gary Remington, Chekkera Shammi
CNS Spectrums|July 27, 2004
The use of pharmacotherapy in the prodrome of schizophreniaGary Remington, Chekkera Shammi
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 19, 2007
Clozapine-induced hypersalivation: a review of treatment strategiesSanjeev Sockalingam, Chekkera Shammi, Gary Remington
The Journal of Clinical Psychiatry|September 18, 2009
Treatment of clozapine-induced hypersalivation with ipratropium bromide: a randomized, double-blind, placebo-controlled crossover studySanjeev Sockalingam, Chekkera Shammi, Gary Remington
British Journal of Hospital Medicine (London, England : 2005)|November 3, 2007
Managing the neuropsychiatric complications of hepatitis C treatmentSanjeev Sockalingam, Chekkera Shammi, Vicky Stergiopoulos
CNS Drugs|September 28, 2005
Augmentation strategies in clozapine-resistant schizophreniaGary Remington, Amitabha Saha, Siow-Ann Chong, et al.
CNS Drugs|February 16, 2006
Augmenting strategies in clozapine-resistant schizophreniaGary Remington, Amitabha Saha, Siow-Ann Chong, et al.
Schizophrenia Research|July 8, 2010
Determining rates of hepatitis C in a clozapine treated cohortSanjeev Sockalingam, Chekkera Shammi, Valerie Powell, et al.
Journal of Clinical Psychopharmacology|November 12, 2005
"Extended" antipsychotic dosing: rationale and pilot dataGary Remington, Philip Seeman, Chekkera Shammi, et al.
Pageof 2